Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

Ipsen to present new data on elafibranor at The Liver Meeting® 2024Launch of Iqirvo® (elafibranor)1 on track with ...

Our team is now focused on the successful execution of our Phase 3 HAE clinical studies.” Recent Highlights and Clinical Study Updates Development Pipeline Upcoming Investor Events and Presentations ...

Alvotech announced the initiation of a confirmatory patient study for AVT16, a proposed biosimilar to ... to research and ...

LOUISVILLE, Ky. -- More than half of patients with newly diagnosed metastatic kidney cancer responded to a novel drug ...

Expects to complete enrollment of the 400-participant sentinel cohort for the COVID-19 Phase 2b study in November 2024 Solid financial position enables Vaxart to attain multiple regulatory and ...

Humacyte, Inc. recently announced the presentation of results from the V007 phase 3 clinical trial of the company’s acel ...

In the final part of our interview, Ticiana Leal, MD, Winship Cancer Institute, looks to the future of perioperative care in the non–small cell lung cancer (NSCLC) arena and the importance of risk ...

WINT Enrolling SCAI Stage C participants in SEISMiC C trial, preparing for Phase 3 readiness Pennsylvania-based Windtree ...

Their Phase 2 MOMENTUM trial for obesity demonstrated significant ... Thus, despite its concentration, regulatory, and ...

November 13, 2024 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, and LimmaTech Biologics AG, a clinical-stage biotech company developing vaccines for the prevention of ...

Longboard Pharmaceuticals has commenced the Phase III DEEp OCEAN Study of its investigational oral drug bexicaserin for ...